Colgate-Palmolive stock steadies in the low-$90s as Q2 2026 earnings beat expectations
Published on 09/01/2026 at 09:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Colgate-Palmolive Inc. (ISIN US1941621039) stock is trading in the low-$90s region as of August 31, 2026, with investors digesting a second-quarter 2026 earnings report that modestly beat profit expectations while delivering steady sales growth.
Per recent market data as of August 31, 2026, Colgate-Palmolive shares opened at $90.75 in the latest New York session, keeping the company’s valuation broadly aligned with other large consumer staples companies.
The latest quarterly figures show that the toothpaste and personal care group remains in an earnings growth phase in 2026, helped by pricing and mix improvements that more than offset cost pressures.
Q2 2026 earnings deliver profit and sales growth
In its most recent quarter, Colgate-Palmolive reported second-quarter 2026 earnings per share of $0.99, exceeding the prevailing consensus forecast of $0.95 and marking a clear positive surprise for investors looking for profit resilience.
That $0.04 beat against consensus equates to a mid-single-digit upside versus expectations, underscoring that the company is able to grow base-business EPS at a faster pace than analysts had penciled in for the period.
Alongside the earnings beat, Colgate-Palmolive’s revenue increased 4.9% year over year in the second quarter of 2026 to $5.36 billion, indicating that the company is still managing to expand its top line despite mature-market exposure and currency headwinds.
Organic sales growth provides a cleaner view of underlying demand trends, and Colgate-Palmolive delivered 2.4% organic sales growth in the quarter, showing that volumes and pricing combined to generate real progress rather than purely nominal gains.
Base-business EPS growth was stronger than the top line, with Colgate-Palmolive achieving 8% base-business EPS growth in second-quarter 2026, suggesting that cost management, price realization and mix were strong enough to lift margins.
The pairing of 2.4% organic sales growth with 8% base-business EPS growth in Q2 2026 illustrates a classic consumer staples pattern in which modest revenue expansion is leveraged into more meaningful profit growth through efficiency gains and disciplined spending.
Analyst expectations and full-year earnings outlook
While the second-quarter 2026 numbers surprised on the upside, investors are also focused on how Colgate-Palmolive’s earnings trajectory looks for the full fiscal year.
Recent coverage of the company’s earnings backdrop indicates that research analysts expect Colgate-Palmolive to post earnings per share of 3.86 for the current fiscal year, implying that the company is on track to deliver solid profit growth over the full 2026 period if quarterly trends persist.
Comparing the second-quarter EPS of $0.99 with the full-year EPS expectation of 3.86 highlights that the company has already delivered more than one quarter of the anticipated annual profit, and that further incremental gains will be needed in the remaining quarters to meet or slightly exceed this forecast.
From an investor perspective, the fact that Colgate-Palmolive beat consensus EPS by $0.04 in Q2 2026 while revenue rose 4.9% year over year suggests that the earnings quality is reasonably high, as profit expansion is supported by both sales growth and operational leverage.
Should the company maintain base-business EPS growth around the 8% mark while sustaining low-to-mid single-digit organic sales increases, the 3.86 full-year EPS expectation would appear achievable, though the path will depend on currency trends, commodity costs and competitive dynamics in oral and personal care.
Stock valuation, trend levels and market positioning
On the market side, Colgate-Palmolive stock continues to reflect its defensive consumer staples profile, with the latest available trading data for August 31, 2026 showing an opening price of $90.75 on the New York Stock Exchange under the ticker CL, where quotations and settlements are in US dollars.
That $90.75 level sits modestly above the company’s 200-day moving average price of $90.03, which serves as a proxy for the longer-term trend line, while standing modestly below the 50-day moving average of $92.02, a gauge of shorter-term momentum.
This positioning, slightly above the 200-day moving average but below the 50-day moving average, indicates that Colgate-Palmolive stock is trading close to its longer-run fair value while lacking the kind of short-term price strength that would signal a clear near-term rally.
For investors, a stock hovering in the low-$90s region with a proven ability to beat earnings expectations and deliver both revenue and EPS growth may represent a steady, income-oriented holding rather than a high-volatility opportunity.
In valuation terms, the combination of a $90.75 share price, mid-single-digit revenue expansion and high-single-digit base-business EPS growth in second-quarter 2026 suggests that Colgate-Palmolive is priced in line with its consumer staples peer group, reflecting its stable but not explosive growth profile.
Product spotlight: Colgate toothpaste franchise
Behind the numbers, Colgate-Palmolive’s core business is anchored by its global toothpaste franchise, where the Colgate brand remains one of the most widely recognized names in oral care around the world.
The company’s oral care portfolio spans a broad range of products, including cavity-protection toothpaste, whitening formulations, sensitivity solutions and children's toothpaste offerings, each tailored to specific consumer needs and regional preferences.
In many markets, Colgate-branded toothpaste holds leading share positions on store shelves, providing the company with a stable base of recurring demand that translates into predictable revenue streams quarter after quarter.
Innovation continues to play a role in sustaining this leadership, with new formulations, packaging formats and targeted marketing campaigns designed to appeal to consumers seeking advanced oral care benefits, such as enamel strengthening, gum health and breath freshness.
The strength of the Colgate toothpaste portfolio helps underpin the company’s broader financial performance, supporting the organic sales growth and base-business EPS gains reported in second-quarter 2026.
Colgate-Palmolive stock and recent trading context
Colgate-Palmolive shares trade on the New York Stock Exchange under the ticker CL, and the US dollar serves as the company’s core currency for stock quotations and shareholder settlements.
As of the latest available opening quote on August 31, 2026, Colgate-Palmolive stock stood at $90.75, a level that places the shares modestly above the 200-day moving average of $90.03 and modestly below the 50-day moving average of $92.02.
For investors monitoring the stock’s technical backdrop, trading slightly above the longer-term moving average suggests a degree of underlying trend stability, while the gap to the 50-day moving average highlights that the shares have not fully recovered short-term momentum despite the second-quarter 2026 earnings beat.
